Takara
Takara Bio Inc., commonly referred to as Takara, is a leading biotechnology company headquartered in Japan (JP). Founded in 1990, Takara has established itself as a key player in the life sciences industry, focusing on innovative solutions for genomic research, molecular biology, and cell biology. With a strong presence in Asia, Europe, and North America, Takara offers a diverse range of products and services, including high-quality reagents, kits, and instruments for DNA and RNA analysis. Their unique offerings, such as the SMART technology for cDNA synthesis, set them apart in the competitive landscape. Recognised for their commitment to quality and innovation, Takara has achieved significant milestones, including numerous patents and collaborations with leading research institutions. Their dedication to advancing scientific research solidifies their position as a trusted partner in the global biotechnology community.
DitchCarbon Score
How does Takara's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Takara's score of 44 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Takara's reported carbon emissions
In 2024, Takara reported total carbon emissions of approximately 11,107,000 kg CO2e for Scope 1, 5,500,000 kg CO2e for Scope 2, and 5,500,000 kg CO2e for Scope 3 emissions, which includes about 2,555,000 kg CO2e from purchased goods and services. This data reflects a comprehensive approach to emissions reporting, covering all three scopes. In 2023, the company recorded emissions of about 10,418,000 kg CO2e for Scope 1, 5,274,000 kg CO2e for Scope 2, and 5,000,000 kg CO2e for Scope 3, indicating a slight increase in emissions across the board compared to 2024. The emissions for 2022 and 2021 were reported as 14,000,000 kg CO2e and 13,000,000 kg CO2e for Scope 1 and 2 combined, respectively, but specific Scope 3 data was not disclosed for those years. Takara has set a significant reduction target to decrease emissions per unit of revenue by 50% compared to fiscal 2019 levels by 2026. This commitment encompasses all scopes of emissions and reflects the company's dedication to improving its emissions intensity. The emissions data is cascaded from its parent company, Takara Bio Inc., which provides a broader context for understanding Takara's climate commitments and performance. The company actively engages in sustainability initiatives, aligning with industry standards to address climate change effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Takara is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
